Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,634 | 35,442 | 26,793 | 29,864 | 18,533 |
| Other current assets | 75 | 145 | 214 | 284 | 74 |
| TOTAL | $31,709 | $35,587 | $27,007 | $30,148 | $18,607 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $31,709 | $35,587 | $27,007 | $30,148 | $18,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,181 | 11,512 | 10,133 | 8,329 | 8,054 |
| Accrued Expenses | 115 | 65 | 2 | 865 | 840 |
| TOTAL | $13,296 | $11,577 | $10,135 | $9,194 | $8,894 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,296 | $11,577 | $10,135 | $9,194 | $8,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,492 | 25,615 | 25,457 | 23,635 | 23,392 |
| Retained earnings | -99,687 | -92,373 | -84,911 | -78,577 | -73,245 |
| TOTAL | $18,413 | $24,010 | $16,872 | $20,954 | $9,713 |
| Total Liabilities And Equity | $31,709 | $35,587 | $27,007 | $30,148 | $18,607 |